2023 | Post Doc ; Division of Physiology & Pathophysiology |
2023 -2023 | Research unit Leader, Ludwig Boltzmann Institute for Lung Vascular Research |
2021 -2023 | Post Doc (Hertha Firnberg FWF); Division of Physiology & Pathophysiology and Ludwig Boltzmann Insitut for Lung Vascular Research (LBI-LVR) |
2019 -2021 | Post-Doc Scientist (Hertha Firnberg FWF); Department of Endocrinology and Diabetology and Ludwig Boltzmann Insitute for Lung VAscular Research (LBI-LVR) |
2015 -2018 | Post Doc Scientist; Ludwig Boltzmann Insitute for Lung Vascular Research (LBI-LVR) |
2010 -2014 | PhD Molecular Medicine Medical University of Graz, Graz, Austria |
2007 -2010 | MSc. in Molecular Medicine Biotechnology,University of Trieste, Trieste, Italy |
2004 -2007 | BSc. in Biotechnology University of Trieste, Trieste, Italy |
2021 | Pilot Call for Public & Patient Involvement and Engagement in Research-SCIENCE4ALL (LBG Open Innovation in Science Center (LBG OIS Center) |
2019 | Hertha Firnberg Program (Austrian Science Fund; FWF) |
2015 | PH UP2DATE offered by Pfizer |
2015 | Michael Neumann Price offered by Österreichischen Gesellschaft für Pneumologie |
2015 | 1st Poster Price, Pulmonale Hypertonie DACH-Symposium |
2013 | American Thoracic Society travel grant offered by Takeda Company and Österreichischen Gesellschaft für Pneumologie |
2020 -2020 | CELLS |
2020 -2020 | METABOLITES |
2017 -2018 | SCIENTIFIC REPORTS |
2024 -2024 | Deutsche Forschungsgemeinschaft ( DFG )- Sonderforschungsbereich - Germany |
2024 -2024 | Fondazione Cariplo - Italy |
2024 -2024 | Longfonds - Netherlands |
2020 -2020 | National Science Center, Poland - Poland |
2023 -2023 | Open Innovation course- Harvard Business School |